Covington & Burling LLP

Life Sciences (International Firms) Department

Current View:

This content is provided by Chambers. Learn more about our methodology

What the team is known for Maintains a commanding position in the life sciences sector, with a particularly strong offering in regulatory issues and extensive experience in investigative matters. Also handles transactional and IP mandates. Retains a highly impressive client base of international pharmaceutical companies, with strength in advising US-based corporates.

Strengths Clients highlight the team's "ability to deal with life sciences cases because of their experience" and confirm that the team is "pretty specialised in this industry."

A market commentator acknowledges: "They are good in regulatory and investigations work, I hold them in high regard."

Notable practitioners

Li Weishi is co-head of the department and is highly praised for her ability to handle cross-border transactions in the life sciences sector. She regularly acts for pharmaceutical companies on joint ventures, licensing issues and CFDA regulatory approvals.